Recall archive / FDA company announcement

VitalityVita: Marketed as Dietary Supplement — FDA announcement Nov 6, 2024

Published notice; closure not supplied

A company announcement posted by FDA. The listing date can differ from the original announcement date. The absence of a termination marker does not prove the recall is currently ongoing.

Source date Nov 6, 2024. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product: Marketed as Dietary Supplement
Reason: Undeclared Sildenafil and Diclofenac
Classification: Not supplied
Recalling firm: VitalityVita
Quantity: Not supplied
Agency-reported status: Company recall announcement
Source record identifier: 37bd0a155cf21035

Open the official record

Lot and product identifiers

Label field	Details supplied by the agency
Lot, code or applicability	FOR IMMEDIATE RELEASE – 11/04/24 – Sacramento, CA, VitalityVita.com is voluntarily recalling lot 230811, Exp 8/11/25, of VitalityXtra Capsules and PeakMax Capsules packaged in 10-count blisters in a cardboard carton to the consumer level. VitalityXtra was found to be tainted with sildenafil, an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. PeakMax capsules was found to be tainted with sildenafil and diclofenac, an FDA approved drug known as a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. Products containing sildenafil and diclofenac cannot be marketed as dietary supplements. VitalityVita and PeakMax capsules are unapproved new drugs for which safety and efficacy have not been established and, therefore, subject to recall.; VitalityXtra and PeakMax are marketed as dietary supplements for male performance and energy and are packaged in 10-count blisters packaged in an (VitalityXtra -Green, Yellow White Carton) and (PeakMax in Purple, Yellow and White carton) Lot#: 230811 Exp 8/11/25. The product can be identified by the labels below.; VitalityVita is notifying its distributors and customers by this press announcement and is arranging for return of all recalled products. Please send all returns to 2108 N ST #7929 Sacramento, CA 95816. Consumers that have VitalityXtra or PeakMax capsules lot number 230811 should stop using the product. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Label field

Details supplied by the agency

Lot, code or applicability

FOR IMMEDIATE RELEASE – 11/04/24 – Sacramento, CA, VitalityVita.com is voluntarily recalling lot 230811, Exp 8/11/25, of VitalityXtra Capsules and PeakMax Capsules packaged in 10-count blisters in a cardboard carton to the consumer level. VitalityXtra was found to be tainted with sildenafil, an ingredient in FDA approved products for treatment of male erectile dysfunction in the family of drugs known as phosphodiesterase (PDE-5) inhibitors. PeakMax capsules was found to be tainted with sildenafil and diclofenac, an FDA approved drug known as a nonsteroidal anti-inflammatory drug (NSAID) used to treat pain and inflammation. Products containing sildenafil and diclofenac cannot be marketed as dietary supplements. VitalityVita and PeakMax capsules are unapproved new drugs for which safety and efficacy have not been established and, therefore, subject to recall.; VitalityXtra and PeakMax are marketed as dietary supplements for male performance and energy and are packaged in 10-count blisters packaged in an (VitalityXtra -Green, Yellow White Carton) and (PeakMax in Purple, Yellow and White carton) Lot#: 230811 Exp 8/11/25. The product can be identified by the labels below.; VitalityVita is notifying its distributors and customers by this press announcement and is arranging for return of all recalled products. Please send all returns to 2108 N ST #7929 Sacramento, CA 95816. Consumers that have VitalityXtra or PeakMax capsules lot number 230811 should stop using the product. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

The products were distributed via the internet at VitalityVita.com nationwide in the USA.

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Fda listing date: Nov 6, 2024
Company announcement date: Nov 4, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.